Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CYTR

CytRx

$1.88

-0.05 (-2.59%)

09:55
04/18/18
04/18
09:55
04/18/18
09:55
Conference/Events
CytRx to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

CYTR

CytRx

$1.93

0.11 (6.04%)

08:09
04/18/18
04/18
08:09
04/18/18
08:09
Hot Stocks
CytRx presents data on LADR candidates at AACR Meeting »

CytRx announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

CYTR

CytRx

$1.87

-0.09 (-4.59%)

09:20
04/16/18
04/16
09:20
04/16/18
09:20
Conference/Events
CytRx to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

Over a month ago
CYTR

CytRx

$1.94

-0.06 (-3.00%)

09:10
03/15/18
03/15
09:10
03/15/18
09:10
Hot Stocks
CytRx selects four LADR candidates for advancement towards clinical trials »

CytRx Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

CYTR

CytRx

$1.56

-0.01 (-0.64%)

09:12
02/28/18
02/28
09:12
02/28/18
09:12
Hot Stocks
CytRx selects Destum Partners as advisor in pharma partnering activities »

CytRx has entered into a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

CYTR

CytRx

$1.77

-0.07 (-3.80%)

09:04
02/05/18
02/05
09:04
02/05/18
09:04
Hot Stocks
CytRx reports initial dosing in carcinoma trial by aldoxorubicin licensee »

CytRx highlighted that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

Over a quarter ago
CYTR

CytRx

$1.77

-0.12 (-6.35%)

09:04
01/17/18
01/17
09:04
01/17/18
09:04
Hot Stocks
CytRx begins dosing in clinical trial for metastatic pancreatic cancer candidate »

CytRx announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

CYTR

CytRx

$1.94

-0.11 (-5.37%)

09:06
12/06/17
12/06
09:06
12/06/17
09:06
Hot Stocks
CytRx files key patent applications for ultra-high potency LADR drug candidates »

CytRx announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

CYTR

CytRx

$1.88

-0.01 (-0.53%)

09:09
11/17/17
11/17
09:09
11/17/17
09:09
Hot Stocks
CytRx regains Nasdaq listing compliance »

CytRx announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTR

CytRx

$2.00

0.13 (6.95%)

09:04
11/13/17
11/13
09:04
11/13/17
09:04
Hot Stocks
CytRx provides business update, announces new shareholder initiatives »

CytRx provided a business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.